We believe that no structure and assumptions should become a barrier to personal treatment. BOH brings the potential of accurate, fast, low cost, actionable, standardized, and routine screening to all cancer patients.
Most used tests for non-communicable diseases (“NCDs”) are blood tests for identifying cardiovascular and cancer diseases (characterized by low counts of biomarkers) and diabetes, amongst other organ-related diseases. Blood tests are expensive and require a lab setting, using a few dozens of molecules and blood-taking by a professional. Blood tests are expensive and require a lab setting, using a few dozens of molecules and blood-taking by a professional. Previous research with breath tests showed very high sensitivity and specificity values for all above mentioned conditions.
Studies have identified over 1,000 VOCs that can be found on breath, alongside respiratory droplets they provide a rich source of information regarding overall health and have great potential as indicators of disease onset and progression.The BOH platform provides ability to detect over 500 molecules and thousands of combinations that can be correlated to diagnostics that are comparable to blood test results, but more affordable, quick and with improved accuracy over time.